bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Cancer of Ovary in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davidson, R; Feig, B; Hu, W; Khokhar, AR; Kumagai, S; Lee, SJ; Maclean, DS; Mansfield, P; Siddik, ZH; Verschraegen, CF | 1 |
al-Baker, S; Han, I; Khokhar, AR; Ling, YH; Perez-Soler, R | 1 |
Han, I; Khokhar, AR; Perez-Soler, R | 1 |
Hong, WK; Huber, M; Khokhar, AR; Lee, SJ; Murphy, WK; Perez-Soler, R; Shin, DM; Siddik, ZH | 1 |
2 trial(s) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Cancer of Ovary
Article | Year |
---|---|
Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Ascites; Carcinoma, Signet Ring Cell; Colorectal Neoplasms; Endometrial Stromal Tumors; Female; Humans; Injections, Intraperitoneal; Liposomes; Male; Mesothelioma; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Peritoneum; Radionuclide Imaging; Technetium; Tissue Distribution | 2003 |
Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Drug Carriers; Female; Humans; Liposomes; Lung Neoplasms; Male; Mesothelioma; Metabolic Clearance Rate; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Rats | 1997 |
2 other study(ies) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Cancer of Ovary
Article | Year |
---|---|
Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
Topics: Antineoplastic Agents; Biological Transport; Cell Survival; Cisplatin; Dimyristoylphosphatidylcholine; DNA, Neoplasm; Drug Carriers; Drug Resistance; Female; Humans; Kinetics; Liposomes; Organoplatinum Compounds; Ovarian Neoplasms; Phosphatidylglycerols; Platinum; Spectrophotometry, Atomic; Tumor Cells, Cultured | 1993 |
Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bis-dichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II).
Topics: Animals; Antineoplastic Agents; Cisplatin; Drug Carriers; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Liposomes; Magnetic Resonance Spectroscopy; Mice; Organoplatinum Compounds; Ovarian Neoplasms; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |